Immunomedics Inc (NASDAQ:IMMU)

44.43
Delayed Data
As of Aug 03
 +2.18 / +5.16%
Today’s Change
8.80
Today|||52-Week Range
44.84
+109.97%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$9.8B

Company Description

Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ.

Contact Information

Immunomedics, Inc.
300 The American Road
Morris Plains New Jersey 07950
P:(844) 323-4668
Investor Relations:
19736058200123

Employees

Shareholders

Other institutional43.93%
Mutual fund holders39.05%
Individual stakeholders22.11%

Top Executives

Usama MalikChief Financial & Business Officer
Loretta M. ItriChief Medical Officer
Brendan DelaneyChief Commercial Officer
Bryan BallChief Quality Officer
William FrickerController